Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan

The outcomes and their predictors, and rates of estimated glomerular filtration rate (eGFR) changes among Taiwanese, an ethnic Chinese population, with chronic kidney disease (CKD) stages 3b–5, enrolled in a nationwide pre-end-stage renal disease (pre-ESRD) management program that have not been prev...

Full description

Bibliographic Details
Main Authors: Chun-Mei Lin, Ming-Chin Yang, Shang-Jyh Hwang, Junne-Ming Sung
Format: Article
Language:English
Published: Elsevier 2013-12-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S092966461300394X
_version_ 1818175070537777152
author Chun-Mei Lin
Ming-Chin Yang
Shang-Jyh Hwang
Junne-Ming Sung
author_facet Chun-Mei Lin
Ming-Chin Yang
Shang-Jyh Hwang
Junne-Ming Sung
author_sort Chun-Mei Lin
collection DOAJ
description The outcomes and their predictors, and rates of estimated glomerular filtration rate (eGFR) changes among Taiwanese, an ethnic Chinese population, with chronic kidney disease (CKD) stages 3b–5, enrolled in a nationwide pre-end-stage renal disease (pre-ESRD) management program that have not been previously reported. Methods: This study focused on a cohort of patients enrolled in the Taiwan's pre-ESRD disease management program from Southern Taiwan, including 4061 CKD 3b–5 patients who received more than 12 weeks of follow-up from 2007 to 2010. The decline rates of eGFR, outcomes, and the predictors of initiating dialysis were analyzed. Results: The study participants consisted of patients who were 70.1 ± 12.3 years old, of whom 56.4% were male, 46.3% were diabetic, and 72.1% were hypertensive. The mean annual eGFR changes were 0.47 ± 0.42 mL/min/1.73 m2/year, −1.27 ± 0.32 mL/min/1.73 m2/year, and −2.69 ± 0.39 mL/min/1.73 m2/year for stages 3b, 4, and 5, respectively; however, more rapid declines were noted in diabetic patients. The Kaplan–Meier analyses revealed that the probabilities of patients remaining alive and free of dialysis treatment for CKD stage 3b, 4, and 5 without or with diabetes were 89.46% versus 84.65%, 79.88% versus 55.68%, and 34.42% versus 9.64%, respectively, during 42 months of follow-up. Male gender, diabetes, lower baseline eGFR, higher systolic blood pressure, lower hematocrit, and albumin levels were the significant risk factors for initiating dialysis. Conclusion: Even though we cannot conclude with certainty that the Taiwan pre-ESRD disease management program is beneficial in slowing the progression of CKD stages 3b–5, our preliminary results seem to suggest this trend. Furthermore, the program may be improved by integrating it with other programs, such as those on diabetes and hypertension, thus making it a more patient-centered, multidisciplinary program.
first_indexed 2024-12-11T19:54:27Z
format Article
id doaj.art-19db50f4434b46b19f01789fd49ebc98
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-11T19:54:27Z
publishDate 2013-12-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-19db50f4434b46b19f01789fd49ebc982022-12-22T00:52:41ZengElsevierJournal of the Formosan Medical Association0929-66462013-12-011121277378210.1016/j.jfma.2013.10.021Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern TaiwanChun-Mei Lin0Ming-Chin Yang1Shang-Jyh Hwang2Junne-Ming Sung3Bureau of National Health Insurance, Taipei, TaiwanGraduate Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, TaiwanDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanDivision of Nephrology, Department of Internal Medicine, National Cheng-Kung University Hospital, Tainan, TaiwanThe outcomes and their predictors, and rates of estimated glomerular filtration rate (eGFR) changes among Taiwanese, an ethnic Chinese population, with chronic kidney disease (CKD) stages 3b–5, enrolled in a nationwide pre-end-stage renal disease (pre-ESRD) management program that have not been previously reported. Methods: This study focused on a cohort of patients enrolled in the Taiwan's pre-ESRD disease management program from Southern Taiwan, including 4061 CKD 3b–5 patients who received more than 12 weeks of follow-up from 2007 to 2010. The decline rates of eGFR, outcomes, and the predictors of initiating dialysis were analyzed. Results: The study participants consisted of patients who were 70.1 ± 12.3 years old, of whom 56.4% were male, 46.3% were diabetic, and 72.1% were hypertensive. The mean annual eGFR changes were 0.47 ± 0.42 mL/min/1.73 m2/year, −1.27 ± 0.32 mL/min/1.73 m2/year, and −2.69 ± 0.39 mL/min/1.73 m2/year for stages 3b, 4, and 5, respectively; however, more rapid declines were noted in diabetic patients. The Kaplan–Meier analyses revealed that the probabilities of patients remaining alive and free of dialysis treatment for CKD stage 3b, 4, and 5 without or with diabetes were 89.46% versus 84.65%, 79.88% versus 55.68%, and 34.42% versus 9.64%, respectively, during 42 months of follow-up. Male gender, diabetes, lower baseline eGFR, higher systolic blood pressure, lower hematocrit, and albumin levels were the significant risk factors for initiating dialysis. Conclusion: Even though we cannot conclude with certainty that the Taiwan pre-ESRD disease management program is beneficial in slowing the progression of CKD stages 3b–5, our preliminary results seem to suggest this trend. Furthermore, the program may be improved by integrating it with other programs, such as those on diabetes and hypertension, thus making it a more patient-centered, multidisciplinary program.http://www.sciencedirect.com/science/article/pii/S092966461300394Xchronic kidney diseasedialysisdisease management programend-stage renal disease
spellingShingle Chun-Mei Lin
Ming-Chin Yang
Shang-Jyh Hwang
Junne-Ming Sung
Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
Journal of the Formosan Medical Association
chronic kidney disease
dialysis
disease management program
end-stage renal disease
title Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
title_full Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
title_fullStr Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
title_full_unstemmed Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
title_short Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
title_sort progression of stages 3b 5 chronic kidney disease preliminary results of taiwan national pre esrd disease management program in southern taiwan
topic chronic kidney disease
dialysis
disease management program
end-stage renal disease
url http://www.sciencedirect.com/science/article/pii/S092966461300394X
work_keys_str_mv AT chunmeilin progressionofstages3b5chronickidneydiseasepreliminaryresultsoftaiwannationalpreesrddiseasemanagementprograminsoutherntaiwan
AT mingchinyang progressionofstages3b5chronickidneydiseasepreliminaryresultsoftaiwannationalpreesrddiseasemanagementprograminsoutherntaiwan
AT shangjyhhwang progressionofstages3b5chronickidneydiseasepreliminaryresultsoftaiwannationalpreesrddiseasemanagementprograminsoutherntaiwan
AT junnemingsung progressionofstages3b5chronickidneydiseasepreliminaryresultsoftaiwannationalpreesrddiseasemanagementprograminsoutherntaiwan